期刊文献+

同型半胱氨酸在帕金森病患者血浆中的变化及临床意义 被引量:4

A study of Plasma Homocystein in Patients with Parkinson's Disease and its Clinical Significance
下载PDF
导出
摘要 目的对比研究同型半胱氨酸(homocystein,Hcy)在帕金森病(Parkinson’s disease,PD)和脑梗死患者血浆中的变化,探讨其临床意义。方法检测PD、脑梗死患者及对照组血浆Hcy水平,检测PD、脑梗死患者及对照组血浆叶酸和维生素B_(12)水平。对PD患者血浆Hcy水平与叶酸及维生素B_(12)水平进行相关性分析,对血浆Hcy水平与PD严重程度、病程、临床类型、情绪、认知功能及是否服用美多芭进行相关性分析。结果 (1)PD组、脑梗死组及对照组血浆Hcy水平分别为20±11μmol/L、16±7μmol/L及11±2μmol/L,PD组和脑梗死组血浆Hcy水平均高于对照组,差异有统计学意义(P<0.05或0.01),PD组血浆Hcy水平明显高于脑梗死组(P<0.01);(2)PD组血浆叶酸和维生素B_(12)水平分别为6±5μg/L和514±345ng/L。PD组血浆叶酸和Hcy水平呈明显负相关(r=-0.453,P<0.01);血浆维生素B_(12)和Hcy水平无明显相关性(r=-0.268,P>0.05)。(3)按照Hoehn-Yahr分期对PD严重程度进行分组,轻、中、重度PD组血浆Hcy水平分别为16±8μmol/L、21±9μmol/L和35±3μmol/L,三组之间差异有统计学意义(P<0.05);(4)血浆Hcy水平与病程、临床类型、情绪、认知功能及是否服用美多芭无关。结论 PD组和脑梗死组血浆Hcy水平明显增高,PD组Hcy水平与疾病严重程度密切相关,PD组血浆叶酸和Hcy水平呈明显负相关。 Objective To conduct a comparsion study on the change of plasma homocystein (Hcy) in patients with Parkinson's disease (PD) and cerebral infarction, and to explore its clinical significance. Methods We examined the levels of plasma Hcy, folic acid and vitamin B12 of patients among PD, cerebral infarction and control group. The levels of plasma Hcy, folic acid and vitamin B12 of PD patients were analyzed. The relationships among Hey level and PD severity, PD duration, clinical types, mood status, cognitive function and Madopar treatment were analyzed. Results 1 Hey levels in patients with PD, cerebral infarction and control group were 20±11 μmol/L, 1617 μmol/L and 11±3μmol/L, respectively. Hey levels in patients with PD and cerebral infarction were all significantly higher than that of control group (P〈0.05 or P〈0.01, respectively). Hcy level in PD patients was significantly higher than that of patients with cerebral infarction (P〈0.01); 2 The levels of plasma folic acid and vitamin B12 in PD patients were 6±5μg/L and 514± 345ng/L; it was negatively correlated (r=-0.453, P〈0.01) between the level of Hcy and folic acid in PD patients; and there was no significant correlation between Hcy level and the level of vitamin BI2 (r=-0.268, P〉0.05); 3 Hey levels in PD patients with mild, moderate and severe degrees evaluated by Hoehn-Yahr staging were significantly different (16±8 μmol/L, 21±9 μmol/L and 35±3 μmol/L, respectively, P〈0.05); 4 There were no relationships among Hey level and PD duration, clinical types, mood status, cognitive function and Madopar treatment. Conclusion Hcy level in PD patients was significantly elevated, which was closely correlated with disease severity. Hey level and folic acid level was negatively correlated.
出处 《中国卒中杂志》 2010年第9期735-740,共6页 Chinese Journal of Stroke
关键词 帕金森病 半胱氨酸 叶酸 脑梗死 Parkinson's disease Cysteine Folic acid Brain infarction
  • 相关文献

参考文献4

二级参考文献38

  • 1Ajmani RS, Rifkind JM. Hemorheologial Changes During Hu man Aging[J].Gerontology(S0304-324X), 1998, 44 (2): 111-120.
  • 2Imamura T, Kiguchi S, Kobayashi K, et al. Effect of Ozagrel, A Selective Thromboxane A2-synthetase Inhibitor, on Cerebral Infarction in Rats. Comparative Study with Norphenazone, A Free-radical Scavenger[J].Arzneimittel Forschung ( S0004 - 4172), 2003,53(10) .688-694.
  • 3Itoh H, Yamatani K, Oshida N, et al. Clinical Effects of Sodium Ozagrel and Urokinase in Patients with Acute Cerebral Infarction in the Territory of the Internal Carotid Artery[J]. No To Shinkei(S0006-8969), 1998,50(2) :147- 155.
  • 4Van Guldener C, Gtehouwer CD. Homocysteine-lowering treatment:an overview[J]. Expert Opin Pyarmacother,2001,2;1449-1460
  • 5Biaskili S, Schiavon R. Homocysteine as a cardiovascular risk factor[J]. Blood Purif,2000,18(3);177-182
  • 6陈键 张金杖 程龙献.高同型半胱氨酸血症,心血管疾病的独立危险因子[J].心血管病学进展,2002,21(2):75-77.
  • 7I Kruman,TS Kumaravel,A Lohani,et al.Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease [J].Neurosci,2002,22:1752.
  • 8SeshADri S.Plasma homocysteine as a risk factor for dementia and Alzheimer's disease [J].New Engl Med,2002,346:476.
  • 9Serot JM.CSF-folate levels are decreased in late-onset AD patients[J].Neural Transm,2001,108:93.
  • 10White AR.Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary cultures,possible risk factors in the Alzheimer's-type neurodegenerative pathways [J].Neurochem,2001,76:1509.

共引文献21

同被引文献37

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部